Kurt M. Eichler, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 1,996 shares at $12.50 ($25K) on 2016-09-16, disclosed to the SEC on 2016-09-20.
Open-market purchase of $25k SBPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 650 | $8K | 32.6% |
| 2 | $12.50 | 1,346 | $17K | 67.4% |
| Total | $12.50 avg | 1,996 | $25K | 100% |
| Filing → |
| SBPH | BUY | 2017-02-27 | $11K | — | Filing → |
| SBPH | BUY | 2016-11-10 | $61K | — | Filing → |
| SBPH | BUY | 2016-09-15 | $6K | — | Filing → |